The administration of Temoporfin involves a two-step process. First, the drug is injected intravenously, allowing it to accumulate in the cancerous tissues. After a specified period, usually around 96 hours, the tumor site is exposed to a specific wavelength of light, typically delivered via a laser. This light activates the Temoporfin, initiating the therapeutic process.
